Search Results (171)

This review classifies plant-derived functional ingredients in pet food according to phytochemical groups and application forms, including direct oral supplementation and incorporation into complete diets. Polyphenols and plant extracts exert prominent antioxidant (singular), anti-inflammatory, immunomodulatory, and microbiome-regulating effects. Microalgae and omega-3 sources support lipid metabolism, cardiovascular function, and skin integrity. Cannabinoids demonstrate dose-dependent responses in dogs, while cats generally tolerate long-term administration and exhibit notable benefits in chronic pain management. Combinations of botanical extracts with complementary bioactives and fermented botanical preparations exhibit multi-target functionality, with dogs showing pronounced biochemical and microbiome modulation, whereas cats display more behavioral and functional improvements. Phytochemicals operate through integrated multi-level regulation, including activation of antioxidant enzymes, modulation of inflammatory cytokines and T-lymphocyte ratios, microbial metabolic shifts toward short-chain fatty acid production, and regulation of lipid metabolism. Dogs demonstrate marked effects on hepatic function, reproductive resilience, microbiome diversity, CD4+/CD8+ balance, and cholesterol control. In contrast, cats show greater benefits in inflammation reduction, pain relief, intestinal integrity, and long-term safety. These species-specific responses underscore the importance of precision formulation and highlight the emergence of plant-based “pharma-pet nutrition” integrating nutritional and biochemical strategies for targeted health promotion. Full article

Amid growing consumer interest in the health benefits of anthocyanins, the market for anthocyanin-based dietary supplements has expanded substantially. However, data on product composition and health claims in the Australian online market remains limited. This study characterises anthocyanin-based dietary supplements available online in Australia (July–August 2024), examining product origin, botanical sources, formulation, extract concentration, delivery formats, anthocyanin content disclosure, health claims, serving sizes and pricing patterns. Among the 121 products analysed, bilberry, elderberry, and tart cherry were the most commonly used anthocyanin sources, collectively representing 47% of the market. Capsules were the dominant delivery format (86%), and reported extract concentrations varied widely, with lower ratios (1–10:1) being most prevalent. Only 18% of products disclosed anthocyanin content (0.1–36%), with bilberry supplements accounting for the majority of reported values. Health claims were present on 69% of products and varied by source, with bilberry products most frequently promoting vision health, elderberry emphasising immune support, tart cherry targeting joint and exercise recovery, and cranberry focusing on urinary tract health. Declared extract (mg per serving) ranged from 10 mg to >1500 mg. Pricing varied substantially across products (AUD 0.02–7.40 per gram; mean AUD 0.78/g), with bilberry supplements consistently among the most expensive. Overall, these findings highlight considerable variability in formulation, disclosure, and health claim practices, underscoring the need for improved transparency and evidence-aligned representation of anthocyanins as bioactive pigments in the Australian nutraceutical market. Full article

Hypertension (HTN) remains a leading modifiable risk factor for cardiovascular disease, and non-pharmacological strategies combining exercise training with plant-derived bioactive supplementation are increasingly recognized as promising adjuncts for blood pressure (BP) management. This evidence-based review synthesizes findings from 31 clinical studies investigating selected plant-based supplements with the strongest available clinical evidence, namely beetroot juice (BRJ), green tea (GT), curcumin (CN), resveratrol (RSV), and garlic, administered alone or in combination with different exercise modalities across acute, short-term, and long-term interventions. Collectively, the evidence indicates that BRJ exerts the most consistent BP-lowering effects, particularly during aerobic training performed at ~50% heart rate reserve (HRR), or ~60% peak oxygen consumption (VO_2peak) in individuals with early-stage vascular dysfunction. CN and garlic also enhance exercise-induced BP reductions, especially in older or metabolically compromised populations. GT shows variable outcomes depending on caffeine content, exercise modality, and participant health status, while RSV provides modest vascular support, often contingent on concurrent training. Mechanistically, these botanicals and exercise converge on key vascular-regulatory pathways, including enhanced nitric oxide (NO) bioavailability, reduced oxidative stress and inflammation, attenuated renin–angiotensin–aldosterone system (RAAS) and sympathetic activity, and improved mitochondrial function through Sirtuin 1 (SIRT1)/AMP-activated protein kinase (AMPK) signaling. Together, these integrated mechanisms improve endothelial function, lower vascular resistance, and ultimately reduce BP. From a translational standpoint, combining exercise with targeted plant-based supplementation offers a safe, accessible, and physiologically synergistic strategy for BP control in clinical populations. Future research should define optimal dosing, timing relative to exercise, and population-specific efficacy to inform precision-based, integrative interventions for HTN management. Full article

As the demand for poultry meat and eggs is increasing in the world, and the use of antibiotics is forbidden in Europe (since 2006), with countries such as the Philippines, Thailand, Bangladesh and China having imposed restriction or prohibitions, researchers and producers have sought for effective non-antibiotic alternatives. Probiotics, prebiotics, synbiotics and phytobiotics are frequently used as alternatives in the field of poultry production. Phytobiotics, plant-derived substances, also referred to as botanicals or phytogenics, are used as animal diets supplements due to their wide range of bioactive compounds (menthol, curcumin, eugenol, allicin and others) and many advantages. They are classified as herbs, spices, plant extracts and essential oils. Some of the benefits offered by the dietary phytobiotics are antimicrobial, antioxidant, digestion stimulant, anti-inflammatory, immunomodulatory, carminative, antiseptic and appetite stimulant, the modulation of gut microbiota and improvement in the intestinal histology. Some representatives of phytobiotics are turmeric, oregano, sage, thyme, black pepper, ginger, garlic, echinacea, rosemary and others. Despite the significant potential of phytobiotics, their widespread adaptation is currently inhibited by challenges regarding cost-effectiveness (high price for raw materials), scarce regulatory frameworks, and inconsistent biological efficacy. The lack of standardization reflects a dual challenge, enclosing both the inherent chemical variability of raw botanical materials and the technical inconsistencies present throughout the industrial manufacturing, and extraction processes as producers use different machinery for extracting and producing the animal feed. To address these systemic impediments, a joint effort across the entire value chain—from primary producers to regulatory authorities—is essential for the development of unified testing protocols and standardization dosage guidelines that ensure the pharmacological safety and reliability of phytobiotic products. Full article

Phosphorus (P) is a vital macronutrient involved in key biochemical processes that support plant growth; however, its low bioavailability in agricultural soils remains a major constraint on crop productivity. This limitation is commonly addressed through the application of chemical P fertilisers produced by acidulation of phosphate rock (PR), a process that is costly, energy-intensive, and environmentally hazardous. This study evaluated the P-solubilising potential of culture filtrates from three fungal strains (Aspergillus flavus JKJ7, Talaromyces purpureogenus JKJ12, and Trichoderma koningiopsis JKJ18) grown in National Botanical Research Institute’s Phosphate (NBRIP) liquid medium supplemented with tricalcium phosphate (TCP), and compared their TCP solubilisation efficiency with that of pure acids (citric and sulfuric acid). All three fungal strains solubilised TCP in NBRIP medium, with A. flavus JKJ7 producing the highest concentration of soluble P (259.81 mg L⁻¹), followed by T. koningiopsis JKJ18 (166.41 mg L⁻¹) and T. purpureogenus JKJ12 (47.07 mg L⁻¹). Soluble P concentrations were inversely correlated with pH and positively correlated with titratable organic acidity (TOA). High-performance liquid chromatography (HPLC) identified citric, succinic, tartaric, and gluconic acids as the dominant organic acids associated with P solubilisation. In pure acid treatments, sulfuric acid exhibited concentration-dependent increases in soluble P, whereas citric acid showed reduced solubilisation efficiency at higher concentrations. Although fungal culture filtrates achieved lower maximum TCP solubilisation than strong mineral acids, their higher TOA contributed to improved stabilisation of soluble P by limiting calcium-mediated reprecipitation. These findings demonstrate that crude fungal organic acid mixtures can complement or partially substitute inorganic acids for mobilising P from low-reactivity PR, offering a potentially cost-effective and environmentally sustainable alternative for P fertiliser production. This study supports the development of biologically derived P inputs aligned with circular bioeconomy and sustainable agriculture goals. Full article

Currently, ω-3 polyunsaturated fatty acids (PUFAs), which have become popular as dietary supplements, are limited by a shortage in supply. Thus, finding safe, effective alternatives is crucial. Echium seed oil (ESO), rich in α-linolenic acid (ALA, 18:3ω-3) and stearidonic acid (SDA, 18:4ω-3), surpasses many other botanical seed oils. In this study, a pseudotargeted approach was applied to characterize the lipidomic profile of two unexplored Echium species from the Mediterranean region. Our findings established Echium glomeratum as a rich source of ω-3 fatty acids (FAs), exceeding many other species in both quality and quantity. E. glomeratum possesses different FAs and triglyceride (TG) profiles compared to E. judaeum, with the ω-3:ω-6 ratio being 3.5 and 1.3, respectively. This corresponds to higher quantities of ALA (45.50%) and SDA (12.59%) in E. glomeratum. Triglycerides (TGs) comprise 93% of the total lipid content in ESO. This study also profiled the most abundant TGs (50–60 carbons) from both species through comprehensive assignment of the olefination patterns. The E. glomeratum oil profile, containing a higher ω-3 PUFA concentration, was further screened for cytotoxic and antioxidant activities. Our preliminary results demonstrated that E. glomeratum ESO may significantly suppress colon cancer cell growth. Full article

The food supplement market has expanded rapidly in recent years, driven by demand for health, wellness, and healthy ageing; yet, the integrity of associated Health Claims (HC) remains uncertain. In the European Union (EU), food supplements are regulated under Directive 2002/46/EC, while HC use is governed by Regulation (EC) No. 1924/2006 (NHCR), which requires scientific substantiation evaluated by the European Food Safety Authority and subsequent authorisation by the European Commission/Member States. Despite this framework, concerns persist regarding unauthorised or non-compliant HC. This study examined the prevalence and compliance of HC on food supplement labels in the Republic of Ireland, comparing products sold in-store and online. A total of 192 food supplements were randomly selected across multiple categories, with HC compliance assessed against the EU Register of Nutrition and Health Claims and mandatory labelling requirements. In total, 2604 HC were identified, with multivitamins and botanicals as the most common categories reviewed. Although most HC referred to vitamins D and C and focused on immune function, only 80.7% of in-store claims and 75.6% of online claims were authorised, and only around one-third used the prescribed wording. Compliance was notably lower for botanicals, reflecting regulatory ambiguities around their use. These findings highlight persistent challenges in enforcing the NHCR, particularly for online sales and botanicals, and underscore the need for greater regulatory clarity and consumer protection. Full article

The human lifespan has increased dramatically over the last few decades; however, reaching older age increases the risk of age-related diseases and ailments. To extend the healthspan, many have turned to supplements, including plant-based remedies used in traditional medicine, to promote healthy aging. One of these is Scutellaria lateriflora L. (S. lateriflora), native to North America, which has traditionally been used to treat anxiety, stress, and insomnia. However, clinical trials addressing its effects are very limited. Furthermore, plant material is intrinsically complex, and the preparation method affects the composition of extracts. We therefore used Drosophila to test whether S. lateriflora can confer resilience against age-related sleep and mobility deficits, using aqueous (SLAq) and ethanol extracts (SLE). Whereas both SLE and SLAq improved mobility, only SLE reduced sleep fragmentation in older males. By testing several flavonoids present in S. lateriflora, we found that the beneficial effects on mobility were mainly due to baicalin, whereas sleep was improved by a wogonin mix. Since neither the extracts nor the compounds extend the lifespan, this suggests that they improve neuronal health and function and do not generally slow down the aging process. This was supported by our finding that neuronal degeneration was reduced by S. lateriflora (SL) supplementation. Full article

Mycotoxins are toxic secondary metabolites produced mainly by filamentous fungi of the genera Aspergillus, Penicillium, and Fusarium and pose a significant food safety concern. This review summarizes current literature on the occurrence of major regulated and emerging mycotoxins, including aflatoxins, ochratoxin A, fumonisins, trichothecenes, zearalenone, and selected Fusarium and Alternaria metabolites, in herbs, spices, and plant-based dietary supplements. Available data indicate that spices—particularly chilli, paprika, ginger, and various types of pepper—represent high-risk commodities and are often more heavily contaminated than dried herbs. Although reported concentrations of individual mycotoxins are frequently low to moderate, numerous studies highlight the common co-occurrence of multiple toxins within a single product, raising concerns regarding cumulative and combined toxic effects. Dietary supplements, especially those containing concentrated plant extracts such as green tea or green coffee, are also identified as potential sources of multi-mycotoxin exposure. The review outlines key analytical approaches for mycotoxin determination, emphasizing the critical role of sample preparation for chromatographic analysis in complex plant matrices. Despite increasing evidence of contamination, important knowledge gaps persist regarding emerging mycotoxins, underrepresented botanical matrices, and long-term exposure assessment, while regulatory limits remain incomplete or inconsistent. Continued monitoring and harmonized analytical and risk assessment strategies are, therefore, essential to ensure consumer safety. Full article

Background and Objectives: Dichrostachys glomerata and Cissus quadrangularis, two species traditionally used in Cameroon, are recognized for their weight-reducing potential. This study examined the effects of standardized extracts of these botanicals on glucagon-like peptide-1 (GLP-1), dipeptidyl peptidase-4 (DPP-4), and key metabolic outcomes in individuals with excess body weight. Materials and Methods: In this 16-week, randomized, double-blind, placebo-controlled trial, 248 adults (126 women and 122 men; mean age 41.3 ± 0.3 years; BMI 25–34.9 kg/m²) were assigned to receive 400 mg D. glomerata extract (DGE), 300 mg C. quadrangularis extract (CQE), semaglutide (dose-escalated from 3 mg to 14 mg), or placebo, administered once daily. These are all standard clinical regimens. Primary assessments included changes in GLP-1 levels and DPP-4 activity. Secondary evaluations included body composition, caloric intake, satiety response, fasting glucose levels, and lipid profiles. Results: Participants receiving DGE or CQE displayed notable elevations in circulating GLP-1 (+38.6 pg/mL and +42.2 pg/mL, respectively; p < 0.01) and significant reductions in DPP-4 activity (−15.3% and −17.8%; p < 0.01) compared with placebo. Both extracts produced substantial improvements in body weight (−5.2% and −5.8%), body fat (−10.3% and −10.9%), energy intake (−16.2% and −17.5%), and satiety (+25.6% and +27.4%) (p < 0.01). Significant changes in fasting glucose and serum lipid levels were also observed (p < 0.05). These responses are comparable to those of semaglutide. Moreover, GLP-1 increments showed strong negative correlations with body fat percentage (r = −0.91 to −0.92; p < 0.001) and DPP-4 activity (r = −0.97 to −0.98; p < 0.001). Conclusions: Supplementation with D. glomerata and C. quadrangularis extracts enhanced GLP-1 secretion and reduced DPP-4 activity, yielding significant benefits for body composition and metabolic parameters. These findings indicate that both botanicals are promising natural agents for managing obesity through incretin-based mechanisms. Full article

Introduction: Chronic low back pain (CLBP) with neuropathic components poses a therapeutic challenge due to the limited efficacy and tolerability of conventional pharmacologic options. Botanical extracts such as Acmella oleracea and Boswellia serrata have demonstrated anti-inflammatory and analgesic properties. This study aimed to explore the role of a food supplement containing a standard formulation of these extracts as an adjunct to standard care in patients with CLBP. Methods: In this prospective, multicenter, observational, real-world, cohort study, 103 patients with CLBP and neuropathic pain received a standardized A. oleracea and B. serrata extract for 8 weeks as an add-on to ongoing therapy. Neuropathic pain was assessed using the painDETECT (PD-Q) and Neuropathic Pain Symptom Inventory (NPSI). General pain intensity (NRS), disability (ODI), quality of life (SF-12), concomitant analgesic use, and safety were also monitored at baseline, and at Weeks 2, 4, and 8. Results: PD-Q scores significantly decreased by 13.4% at Week 2, 25.5% at Week 4, and 37.1% at Week 8 and NPSI scores decreased by 15.8%, 24.4%, and 36.9%, respectively (all p < 0.0001 vs. baseline). NRS pain intensity improved by 28.0% by Week 8 (p < 0.0001). ODI scores reduced by 20.8% (p < 0.0001) and SF-12 scores improved by 4.1% (p < 0.001) compared to baseline. Use of NSAIDs and gabapentinoids decreased by 23.7%, and 22.2%, respectively (p < 0.05). No serious adverse events occurred; mild and transient effects were reported in 8.7% of patients. Conclusions: The A. oleracea and B. serrata extract as adjunctive therapy resulted in significant improvements in neuropathic pain, functional disability, and reduced medication use, with good tolerability. While these findings suggest a potential role for this botanical combination in managing CLBP with neuropathic components, the absence of a control group limits causal inference. Randomized controlled trials are needed to establish efficacy and confirm these preliminary observations. Full article

Oxalis corniculata L. (O. corniculata) has attracted increasing attention as a natural source of antioxidants with diverse pharmacological potential. Phytochemical studies have identified a diverse spectrum of metabolites, dominated by flavonoids, polysaccharides, and organic acids. These compounds exhibit antioxidant properties as well as related biological activities, including anti-inflammatory, antimicrobial, neuroprotective, hypoglycemic, and anticancer effects. Its long-standing use in traditional remedies, along with its incorporation into approved Chinese patent medicines, underscores its safety and translational value. This review synthesizes recent advances in the chemical composition, bioactivities, and molecular mechanisms of O. corniculata, emphasizing its antioxidant-driven pharmacological prospects. The review highlights O. corniculata as a sustainable and accessible botanical resource with significant potential for the development of pharmaceuticals, dietary supplements, and health-promoting applications. Full article

Dietary supplements provide essential nutrients and bioactive compounds that enhance health and traditional therapies. However, the quality and composition of these supplements can vary significantly, potentially containing inconsistent levels of active ingredients or undisclosed risk substances. Due to the current extensive industrial applications, bisphenols (BPs) and alkylphenols (APs) have become environmentally ubiquitous. Substantial evidence indicates that these compounds exhibit endocrine-disrupting properties, posing potential health risks to humans. The detection of trace-level BPs and APs in dietary supplements is critical. This study developed a supramolecular solvent (SUPRAS) from a water/THF/1-hexanol system under mild conditions for analyzing 19 BPs and APs in commercial botanical dietary supplements. After optimizing SUPRAS preparation and extraction parameters, we established a SUPRAS–HPLC–MS/MS method enabling one-step extraction/cleanup within 10 min for tablets, capsules, and oral liquids, with high sensitivity and simplicity. The method scored 0.71 (out of 1) on the AGREE metric, confirming its green profile. Detectable levels of bisphenol A (178.7–452.6 μg/kg) and 4-pentylphenol (145.3 μg/kg) in marketed products highlight potential health risks from botanical dietary supplement-derived exposure. Full article

The rising use of medicinal plant food supplements in Europe reflects a growing consumer shift toward natural health solutions and sustainability-driven lifestyles. The study aims to synthesize current literature and regulatory frameworks to better understand the drivers behind medicinal plant food supplements use and the challenges within the botanical products market. Findings reveal that usage patterns are strongly influenced by age, gender, income, education level, and cultural traditions, with women, older adults, and health-conscious individuals leading consumption. Consumers increasingly demand products that are organic, traceable, and ethically sourced, aligning with broader sustainability goals. However, discrepancies in national regulations, transparency in labeling, and environmental concerns such as over-harvesting persist across the European Union (EU). The distinction between Food Supplements (FSs) and Traditional Herbal Medicinal Products (THMPs) under current EU directives contributes to market fragmentation and consumer confusion. In conclusion, harmonizing regulatory standards, promoting responsible sourcing, and integrating traditional knowledge into sustainable production models are essential for ensuring safety, consumer trust, and long-term ecological viability in the medicinal plant food supplement sector. Full article

Laying hens in the late laying period often experience reduced productivity and declining egg and meat quality, which limits breeding efficiency and resource utilization. This study aimed to evaluate the effects of multi-component Botanical Crude Extracts (BCEs) on egg and meat quality, metabolic health, and gut microbiota in aged laying hens. A total of 4320 hens were supplemented with 0.3% BCEs for 100 days, with evaluations at 60 and 100 days. BCE supplementation significantly enhanced egg flavor by promoting aromatic and fat-soluble volatiles and reducing odorous compounds (p < 0.05). BCEs improved yolk nutrition by enriching n-3 polyunsaturated fatty acids, especially docosahexaenoic acid (DHA), and optimizing the n-6/n-3 ratio (p < 0.05). A moderate reduction in amino acids was observed, which may reduce bitterness and ammonia burden (0.05 ≤ p < 0.10, trend). In muscle, BCEs improved protein–fat distribution, increased intramuscular fat, and enhanced flavor-related metabolites, significantly improving meat quality of culled hens (p < 0.05). BCEs also reshaped gut microbiota, reducing harmful taxa and promoting short-chain fatty acid and aromatic metabolite biosynthesis (p < 0.05). Serum metabolomics revealed modulation of AMPK, calcium, and cholesterol pathways, improving antioxidant capacity and lipid regulation (p < 0.05). Correlation analyses linked beneficial bacteria and metabolites with yolk DHA levels and flavor (p < 0.05). Overall, BCEs enhanced egg and meat quality and physiological health, providing guidance for functional feed strategies in aged laying hens. Full article